Publications

  1. Tang S, Venkatakrishnan SV, Chowdhury MSN, Yang D, Gober M, Nelson GJ, Cekanova M, Biris AS, Buzzard GT, Bouman CA, Skorpenske HD, Bilheux HZ. A machine learning decision criterion for reducing scan time for hyperspectral neutron computed tomography systems. Sci Rep. 2024 Jul 2; 14 (1):15171 Epub 2024 July 02
    View PubMed
  2. Guida SJ, Bartges Y, Jones R, Young C, Cekanova M. Comparison of Multiplex Real-Time PCR with Standard Urine Culture for Identification of Pathogens Associated with Canine Urinary Tract Infections Appli Microbiol Open Access. 2023; 9(2):253.
  3. Brugger A, Bilheux HZ, Lin JYY, Nelson GJ, Kiss AM, Morris J, Connolly MJ, Long AM, Tremsin AS, Strzelec A, Anderson MH, Agasie R, Finney CEA, Wissink ML, Hubler MH, Pellenq RJ, White CE, Heuser BJ, Craft AE, Harp JM, Tan C, Morris K, Junghans A, Sevanto S, Warren JM, Esteban Florez FL, Biris AS, Cekanova M, Kardjilov N, Schillinger B, Frost MJ, Vogel SC. The Complex, Unique, and Powerful Imaging Instrument for Dynamics (CUPI2D) at the Spallation Neutron Source (invited). Rev Sci Instrum. 2023 May 1; 94 (5)
    View PubMed
  4. Bilheux HZ, Cekanova M, Warren JM, Meagher MJ, Ross RD, Bilheux JC, Venkatakrishnan S, Lin JYY, Zhang Y, Pearson MR, Stringfellow E. Neutron Radiography and Computed Tomography of Biological Systems at the Oak Ridge National Laboratory's High Flux Isotope Reactor. J Vis Exp. 2021 May 7; (171) Epub 2021 May 07
    View PubMed
  5. Cekanova M, Pandey S, Olin S, Ryan P, Stokes JE, Hecht S, Martin-Jimenez T, Uddin MJ, Marnett LJ. Pharmacokinetic characterization of fluorocoxib D, a cyclooxygenase-2-targeted optical imaging agent for detection of cancer. J Biomed Opt. 2020 Aug; 25 (8)
    View PubMed
  6. Bourn J, Rathore K, Donnell R, White W, Uddin MJ, Marnett L, Cekanova M. Detection of carcinogen-induced bladder cancer by fluorocoxib A. BMC Cancer. 2019 Nov 27; 19 (1):1152
    View PubMed
  7. Bourn J, Pandey S, Uddin J, Marnett L, Cekanova M. Detection of tyrosine kinase inhibitors-induced COX-2 expression in bladder cancer by fluorocoxib A. Oncotarget. 2019 Aug 27; 10 (50):5168-5180
    View PubMed
  8. Pandey S, Hickey DU, Drum M, Millis DL, Cekanova M. Platelet-rich plasma affects the proliferation of canine bone marrow-derived mesenchymal stromal cells in vitro. BMC Vet Res. 2019 Jul 30; 15 (1):269 Epub 2019 July 30
    View PubMed
  9. Pandey S, Rathore K, Johnson J, Cekanova M. Aligned nanofiber material supports cell growth and increases osteogenesis in canine adipose-derived mesenchymal stem cells in vitro. J Biomed Mater Res A. 2018 Jul; 106 (7):1780-1788 Epub 2018 Mar 06
    View PubMed
  10. Pandey S, Bourn J, Cekanova M. Mutations of p53 decrease sensitivity to the anthracycline treatments in bladder cancer cells. Oncotarget. 2018 Jun 19; 9 (47):28514-28531 Epub 2018 June 19
    View PubMed
  11. Bourn J, Cekanova M. Cyclooxygenase inhibitors potentiate receptor tyrosine kinase therapies in bladder cancer cells in vitro. Drug Des Devel Ther. 2018; 12:1727-1742 Epub 2018 June 13
    View PubMed
  12. Smolensky D, Rathore K, Bourn J, Cekanova M. Inhibition of the PI3K/AKT Pathway Sensitizes Oral Squamous Cell Carcinoma Cells to Anthracycline-Based Chemotherapy In Vitro. J Cell Biochem. 2017 Sep; 118 (9):2615-2624 Epub 2017 May 16
    View PubMed
  13. Sadler RA, Schumacher JP, Rathore K, Newkirk KM, Cole G, Seibert R, Cekanova M. Evaluation of the role of the cyclooxygenase signaling pathway during inflammation in skin and muscle tissues of ball pythons (Python regius). Am J Vet Res. 2016 May; 77 (5):487-94
    View PubMed
  14. Smolensky D, Rathore K, Cekanova M. Molecular targets in urothelial cancer: detection, treatment, and animal models of bladder cancer. Drug Des Devel Ther. 2016; 10:3305-3322 Epub 2016 Oct 05
    View PubMed
  15. Rathore K, Cekanova M. Effects of environmental carcinogen benzo(a)pyrene on canine adipose-derived mesenchymal stem cells. Res Vet Sci. 2015 Dec; 103:34-43 Epub 2015 Sept 14
    View PubMed
  16. Smolensky D, Rathore K, Cekanova M. Phosphatidylinositol- 3-kinase inhibitor induces chemosensitivity to a novel derivative of doxorubicin, AD198 chemotherapy in human bladder cancer cells in vitro. BMC Cancer. 2015 Nov 23; 15:927
    View PubMed
  17. Wimalasena J, Cekanova M, Pestell RG, Fernando RI. Roles of BCL2 and BAD in Breast Cancer Journal of Clinical & Cellular Immunology. 2015; 6(4):352.
  18. Bilheux HZ, Cekanova M, Vass AA, Nichols TL, Bilheux JC, Donnell RL, Finochiarro V. A novel approach to determine post mortem interval using neutron radiography. Forensic Sci Int. 2015 Jun; 251:11-21 Epub 2015 Mar 06
    View PubMed
  19. Cekanova M, Fernando RI, Siriwardhana N, Sukhthankar M, Parra C, Woraratphoka J, Malone C, Strom A, Baek SJ, Wade PA, Saxton AM, Donnell RM, Pestell RG, Dharmawardhane S, Wimalasena J. BCL-2 family protein, BAD is down-regulated in breast cancer and inhibits cell invasion. Exp Cell Res. 2015 Feb 1; 331 (1):1-10 Epub 2014 Dec 09
    View PubMed
  20. Rathore K, Cekanova M. A novel derivative of doxorubicin, AD198, inhibits canine transitional cell carcinoma and osteosarcoma cells in vitro. Drug Des Devel Ther. 2015; 9:5323-35 Epub 2015 Sept 25
    View PubMed
  21. Rathore K, Alexander M, Cekanova M. Piroxicam inhibits Masitinib-induced cyclooxygenase 2 expression in oral squamous cell carcinoma cells in vitro. Transl Res. 2014 Aug; 164 (2):158-68 Epub 2014 Feb 21
    View PubMed
  22. Rathore K, Cekanova M. Animal model of naturally occurring bladder cancer: characterization of four new canine transitional cell carcinoma cell lines. BMC Cancer. 2014 Jun 25; 14:465 Epub 2014 June 25
    View PubMed
  23. Cekanova M, Rathore K. Animal models and therapeutic molecular targets of cancer: utility and limitations. Drug Des Devel Ther. 2014; 8:1911-21 Epub 2014 Oct 14
    View PubMed
  24. Cekanova M, Uddin MJ, Bartges JW, Callens A, Legendre AM, Rathore K, Wright L, Carter A, Marnett LJ. Molecular imaging of cyclooxygenase-2 in canine transitional cell carcinomas in vitro and in vivo. Cancer Prev Res (Phila). 2013 May; 6 (5):466-76 Epub 2013 Mar 26
    View PubMed
  25. Siriwardhana N, Kalupahana NS, Cekanova M, LeMieux M, Greer B, Moustaid-Moussa N. Modulation of adipose tissue inflammation by bioactive food compounds. J Nutr Biochem. 2013 Apr; 24 (4):613-23
    View PubMed
  26. Cekanova M, Uddin MJ, Legendre AM, Galyon G, Bartges JW, Callens A, Martin-Jimenez T, Marnett LJ. Single-dose safety and pharmacokinetic evaluation of fluorocoxib A: pilot study of novel cyclooxygenase-2-targeted optical imaging agent in a canine model. J Biomed Opt. 2012 Nov; 17 (11):116002
    View PubMed
  27. Peretich A, Cekanova M, Hurst S, Baek SJ, Dhar M. PPAR? Agonists Down-Regulate the Expression of mRNA during Adipogenesis The Open Obesity Journal. 2010; 2009(1):41-48.
  28. Cekanova M, Lee SH, McEntee MF, Baek SJ. MCC-555-induced NAG-1 expression is mediated in part by KLF4. Eur J Pharmacol. 2010 Jul 10; 637 (1-3):30-7 Epub 2010 Apr 10
    View PubMed
  29. Cekanova M, Lee SH, Donnell RL, Sukhthankar M, Eling TE, Fischer SM, Baek SJ. Nonsteroidal anti-inflammatory drug-activated gene-1 expression inhibits urethane-induced pulmonary tumorigenesis in transgenic mice. Cancer Prev Res (Phila). 2009 May; 2 (5):450-8 Epub 2009 Apr 28
    View PubMed
  30. Yamaguchi K, Cekanova M, McEntee MF, Yoon JH, Fischer SM, Renes IB, Van Seuningen I, Baek SJ. Peroxisome proliferator-activated receptor ligand MCC-555 suppresses intestinal polyps in ApcMin/+ mice via extracellular signal-regulated kinase and peroxisome proliferator-activated receptor-dependent pathways. Mol Cancer Ther. 2008 Sep; 7 (9):2779-87
    View PubMed
  31. Cekanova M, Yuan JS, Li X, Kim K, Baek SJ. Gene alterations by peroxisome proliferator-activated receptor gamma agonists in human colorectal cancer cells. Int J Oncol. 2008 Apr; 32 (4):809-19
    View PubMed
  32. Lee SH, Cekanova M, Baek SJ. Multiple mechanisms are involved in 6-gingerol-induced cell growth arrest and apoptosis in human colorectal cancer cells. Mol Carcinog. 2008 Mar; 47 (3):197-208
    View PubMed
  33. Fernando R, Foster JS, Bible A, Strom A, Pestell RG, Rao M, Saxton A, Baek SJ, Yamaguchi K, Donnell R, Cekanova M, Wimalasena J. Breast cancer cell proliferation is inhibited by BAD: regulation of cyclin D1. J Biol Chem. 2007 Sep 28; 282 (39):28864-28873 Epub 2007 Aug 01
    View PubMed
  34. Cekanova M, Majidy M, Masi T, Al-Wadei HA, Schuller HM. Overexpressed Raf-1 and phosphorylated cyclic adenosine 3'-5'-monophosphatate response element-binding protein are early markers for lung adenocarcinoma. Cancer. 2007 Mar 15; 109 (6):1164-73
    View PubMed
  35. Laag E, Majidi M, Cekanova M, Masi T, Takahashi T, Schuller HM. NNK activates ERK1/2 and CREB/ATF-1 via beta-1-AR and EGFR signaling in human lung adenocarcinoma and small airway epithelial cells. Int J Cancer. 2006 Oct 1; 119 (7):1547-52
    View PubMed
  36. Cekanova M, Masi T, Plummer HK 3rd, Majidi M, Fedorocko P, Schuller HM. Pulmonary fibroblasts stimulate the proliferation of cell lines from human lung adenocarcinomas. Anticancer Drugs. 2006 Aug; 17 (7):771-81
    View PubMed
  37. Askari MD, Tsao MS, Cekanova M, Schuller HM. Ethanol and the tobacco-specific carcinogen, NNK, contribute to signaling in immortalized human pancreatic duct epithelial cells. Pancreas. 2006 Jul; 33 (1):53-62
    View PubMed
  38. Schuller HM, Kabalka G, Smith G, Mereddy A, Akula M, Cekanova M. Detection of overexpressed COX-2 in precancerous lesions of hamster pancreas and lungs by molecular imaging: implications for early diagnosis and prevention. ChemMedChem. 2006 Jun; 1 (6):603-10
    View PubMed
  39. Masi T, Cekanova M, Walker K, Bernert H, Majidi M, Becker JM, Schuller HM. Nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced pulmonary adenocarcinomas in Syrian golden hamsters contain beta 2-adrenergic receptor single-nucleotide polymorphisms. Genes Chromosomes Cancer. 2005 Oct; 44 (2):212-7
    View PubMed
  40. Plummer HK 3rd, Dhar MS, Cekanova M, Schuller HM. Expression of G-protein inwardly rectifying potassium channels (GIRKs) in lung cancer cell lines. BMC Cancer. 2005 Aug 18; 5:104
    View PubMed
  41. Schuller HM, Cekanova M. NNK-induced hamster lung adenocarcinomas over-express beta2-adrenergic and EGFR signaling pathways. Lung Cancer. 2005 Jul; 49 (1):35-45 Epub 2005 Feb 16
    View PubMed
  42. Bukovsky A, Indrapichate K, Fujiwara H, Cekanova M, Ayala ME, Dominguez R, Caudle MR, Wimalsena J, Elder RF, Copas P, Foster JS, Fernando RI, Henley DC, Upadhyaya NB. Multiple luteinizing hormone receptor (LHR) protein variants, interspecies reactivity of anti-LHR mAb clone 3B5, subcellular localization of LHR in human placenta, pelvic floor and brain, and possible role for LHR in the development of abnormal pregnancy, pelvic floor disorders and Alzheimer's disease. Reprod Biol Endocrinol. 2003 Jun 3; 1:46 Epub 2003 June 03
    View PubMed
  43. Bukovsky A, Caudle MR, Cekanova M, Fernando RI, Wimalasena J, Foster JS, Henley DC, Elder RF. Placental expression of estrogen receptor beta and its hormone binding variant--comparison with estrogen receptor alpha and a role for estrogen receptors in asymmetric division and differentiation of estrogen-dependent cells. Reprod Biol Endocrinol. 2003 Apr 15; 1:36
    View PubMed
  44. Bukovsky A, Cekanova M, Caudle MR, Wimalasena J, Foster JS, Henley DC, Elder RF. Expression and localization of estrogen receptor-alpha protein in normal and abnormal term placentae and stimulation of trophoblast differentiation by estradiol. Reprod Biol Endocrinol. 2003 Feb 6; 1:13 Epub 2003 Feb 06
    View PubMed
  45. Bukovsky A, Cekanova M, Caudle MR, Wimalasena J, Foster JS, Keenan JA, Elder RF. Variability of placental expression of cyclin E low molecular weight variants. Biol Reprod. 2002 Aug; 67 (2):568-74
    View PubMed
  46. Solar P, Cavarga I, Hofmanova J, Cekanova-Figurova M, Cekanová-Figurová M, Miskovsky P, Brezani P, Hrckova G, Kozubik A, Fedorocko P. Effect of acetazolamide on hypericin photocytotoxicity. Planta Med 2002 Jul; 68 (7):658-60
    View PubMed
  47. Cavarga I, Brezani P, Cekanova-Figurova M, Cekanová-Figurová M, Solar P, Fedorocko P, Miskovsky P. Photodynamic therapy of murine fibrosarcoma with topical and systemic administration of hypericin. Phytomedicine. 2001 Sep; 8 (5):325-30
    View PubMed
  48. Bukovsky A, Copas P, Caudle MR, Cekanova M, Dassanayake T, Asbury B, Van Meter SE, Elder RF, Brown JB, Cross SB. Abnormal expression of p27kip1 protein in levator ani muscle of aging women with pelvic floor disorders - a relationship to the cellular differentiation and degeneration. BMC Clin Pathol. 2001; 1 (1):4
    View PubMed